Sharlene Gill, Medical Oncologist and Medical Director of Staff Wellness and Engagement at BC Cancer, shared a post on LinkedIn:
“Congrats to Dr Thiago do Amaral Miranda from BC Cancer!
Check out his poster!
In the era of nivo/ipi for dMMR mCRC, can we predict pts who may do well with PD1/pembro alone?
- absence of liver mets
- primary tumour resected
- ECOG 0-1
Our real-world experience correlated well with KN177.
Our patients have options – interested to see how/if the COMMIT data to be presented this afternoon will influence this landscape.”
More posts from ASCO GI26.